188 related articles for article (PubMed ID: 7951107)
1. Possible transmission of sarcoidosis via allogeneic bone marrow transplantation.
Heyll A; Meckenstock G; Aul C; Söhngen D; Borchard F; Hadding U; Mödder U; Leschke M; Schneider W
Bone Marrow Transplant; 1994 Jul; 14(1):161-4. PubMed ID: 7951107
[TBL] [Abstract][Full Text] [Related]
2. Successful allogeneic bone marrow transplantation for early relapse after autologous bone marrow transplantation in two cases of aggressive high-grade non-Hodgkin's lymphoma.
Moreau P; Méchinaud F; Mahé B; Le Tortorec S; Rapp MJ; Maisonneuve H; Harousseau JL; Milpied N
Bone Marrow Transplant; 1996 Sep; 18(3):665-7. PubMed ID: 8879639
[TBL] [Abstract][Full Text] [Related]
3. Impact of cyclosporine and methylprednisolone dose used for prophylaxis and therapy of graft-versus-host disease on survival and relapse after allogeneic bone marrow transplantation.
Michallet M; Perrin MC; Belhabri A; Molina L; Nicolini F; Tigaud JD; Sotto JJ; Guyotat D; Fière D; Archimbaud E
Bone Marrow Transplant; 1999 Jan; 23(2):145-50. PubMed ID: 10197799
[TBL] [Abstract][Full Text] [Related]
4. Allogeneic bone marrow transplantation for relapsed and refractory Hodgkin's disease and non-Hodgkin's lymphoma.
Dann EJ; Daugherty CK; Larson RA
Bone Marrow Transplant; 1997 Sep; 20(5):369-74. PubMed ID: 9339751
[TBL] [Abstract][Full Text] [Related]
5. The treatment of relapsed or refractory intermediate grade non-Hodgkin's lymphoma with autologous bone marrow transplantation followed by cyclosporine and interferon.
Gryn J; Johnson E; Goldman N; Devereux L; Grana G; Hageboutros A; Fernandez E; Constantinou C; Harrer W; Viner E; Goldberg J
Bone Marrow Transplant; 1997 Feb; 19(3):221-6. PubMed ID: 9028549
[TBL] [Abstract][Full Text] [Related]
6. CD6+ T cell-depleted allogeneic bone marrow transplantation for non-Hodgkin's lymphoma.
Soiffer RJ; Freedman AS; Neuberg D; Fisher DC; Alyea EP; Gribben J; Schlossman RL; Bartlett-Pandite L; Kuhlman C; Murray C; Freeman A; Mauch P; Anderson KC; Nadler LM; Ritz J
Bone Marrow Transplant; 1998 Jun; 21(12):1177-81. PubMed ID: 9674848
[TBL] [Abstract][Full Text] [Related]
7. Bone marrow transplantation after failure of autologous transplant for non-Hodgkin's lymphoma.
de Lima M; van Besien KW; Giralt SA; Khouri IF; Mehra R; Andersson BS; Przepiorka D; Gajewski JL; Korbling M; Champlin RE
Bone Marrow Transplant; 1997 Jan; 19(2):121-7. PubMed ID: 9116608
[TBL] [Abstract][Full Text] [Related]
8. Long-term follow-up of allogeneic bone marrow transplantation in patients with poor prognosis non-Hodgkin's lymphoma.
Bernard M; Dauriac C; Drénou B; Leberre C; Branger B; Fauchet R; Le Prisé PY; Lamy T
Bone Marrow Transplant; 1999 Feb; 23(4):329-33. PubMed ID: 10100576
[TBL] [Abstract][Full Text] [Related]
9. Resolution of sarcoidosis after allogeneic bone marrow transplantation with donor lymphocyte infusions.
Tauro S; Mahendra P
Bone Marrow Transplant; 2001 Apr; 27(7):757-9. PubMed ID: 11360118
[TBL] [Abstract][Full Text] [Related]
10. Bronchiolitis obliterans organizing pneumonia and ulcerative colitis after allogeneic bone marrow transplantation.
Baron FA; Hermanne JP; Dowlati A; Weber T; Thiry A; Fassotte MF; Fillet G; Beguin Y
Bone Marrow Transplant; 1998 May; 21(9):951-4. PubMed ID: 9613791
[TBL] [Abstract][Full Text] [Related]
11. T cell-depleted allogeneic bone marrow transplantation for high-risk non-Hodgkin's lymphoma: clinical and molecular follow-up.
Juckett M; Rowlings P; Hessner M; Keever-Taylor C; Burns W; Camitta B; Casper J; Drobyski WR; Hanson G; Horowitz M; Lawton C; Margolis J; Peitryga D; Vesole D
Bone Marrow Transplant; 1998 May; 21(9):893-9. PubMed ID: 9613781
[TBL] [Abstract][Full Text] [Related]
12. Donor cell-derived sarcoidosis after allogeneic BMT.
Morita R; Hashino S; Kubota K; Onozawa M; Kahata K; Kondo T; Suzuki S; Matsuno Y; Imamura M; Asaka M
Bone Marrow Transplant; 2009 Mar; 43(6):507-8. PubMed ID: 18955983
[No Abstract] [Full Text] [Related]
13. Allogeneic transplantation for recurrent or refractory non-Hodgkin's lymphoma with poor prognostic features after conditioning with thiotepa, busulfan, and cyclophosphamide: experience in 44 consecutive patients.
van Besien K; Thall P; Korbling M; Pugh WC; Khouri I; Mehra R; Giralt S; Anderlini P; Amin K; Mirza N; Seong D; Gajewski J; Hester J; Andersson B; Cabanillas F; Champlin R; Przepiorka D
Biol Blood Marrow Transplant; 1997 Aug; 3(3):150-6. PubMed ID: 9310192
[TBL] [Abstract][Full Text] [Related]
14. [Prevention of hepatitis B flare-up using lamivudine in a patient with non-Hodgkin's lymphoma after allogeneic bone marrow transplantation].
Sunami K; Fujiwara T; Yoshida C; Fujii S; Fukuda S; Sezaki T
Rinsho Ketsueki; 2000 Sep; 41(9):733-8. PubMed ID: 11070935
[TBL] [Abstract][Full Text] [Related]
15. Allogeneic bone marrow transplantation for poor-prognosis non-Hodgkin's lymphoma.
Shepherd JD; Barnett MJ; Connors JM; Spinelli JJ; Sutherland HJ; Kingemann HG; Nantel SH; Reece DE; Currie CJ; Phillips GL
Bone Marrow Transplant; 1993 Dec; 12(6):591-6. PubMed ID: 8136743
[TBL] [Abstract][Full Text] [Related]
16. Allogeneic or autologous bone marrow transplantation (BMT) for non-Hodgkin's lymphoma (NHL): results of a provincial strategy. Ontario BMT Network, Canada.
Schimmer AD; Jamal S; Messner H; Keating A; Meharchand J; Huebsch L; Walker I; Benger A; Gluck S; Smith A
Bone Marrow Transplant; 2000 Oct; 26(8):859-64. PubMed ID: 11081385
[TBL] [Abstract][Full Text] [Related]
17. Management of lymphoma recurrence after allogeneic transplantation: the relevance of graft-versus-lymphoma effect.
van Besien KW; de Lima M; Giralt SA; Moore DF; Khouri IF; Rondón G; Mehra R; Andersson BS; Dyer C; Cleary K; Przepiorka D; Gajewski JL; Champlin RE
Bone Marrow Transplant; 1997 May; 19(10):977-82. PubMed ID: 9169641
[TBL] [Abstract][Full Text] [Related]
18. Clinical outcome following autologous and allogeneic blood and marrow transplantation for relapsed diffuse large-cell non-Hodgkin's lymphoma.
Aksentijevich I; Jones RJ; Ambinder RF; Garrett-Mayer E; Flinn IW
Biol Blood Marrow Transplant; 2006 Sep; 12(9):965-72. PubMed ID: 16920563
[TBL] [Abstract][Full Text] [Related]
19. Late-onset renal dysfunction in a patient with non-Hodgkin's lymphoma following an autologous bone marrow transplantation.
Tamura H; Mitarai T; Niimi Y; Kato H; Matsumura O; Isoda K
Nihon Jinzo Gakkai Shi; 1995 Aug; 37(8):474-80. PubMed ID: 7563957
[TBL] [Abstract][Full Text] [Related]
20. Increasing incidence of diffuse alveolar hemorrhage following allogeneic bone marrow transplantation: cryptic etiology and uncertain therapy.
Lewis ID; DeFor T; Weisdorf DJ
Bone Marrow Transplant; 2000 Sep; 26(5):539-43. PubMed ID: 11019844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]